by IRWIN Z. ROTHENBERG, MBA, MS, CLS(ASCP)
The Protecting Access to Medicare Act (PAMA) includes the most extensive reform of the Medicare Clinical Laboratory Fee Schedule (CLFS) since it was established in 1984. Signed into law on April 1, 2014, PAMA was intended to introduce market-based pricing to the Medicare CLFS. PAMA was passed after it was discovered by the Health and Human Services’ Office of Inspector General (OIG) that Medicare paid significantly more for clinical laboratory tests than commercial payers, and in some cases, Medicaid1.
by BARRY CRAIG
The landscape for lab testing is changing and we must be able to adapt or go up in a puff of smoke! All is not doom and gloom, we can prevail.
Here are some tips related to testing, billing, etc.